1. Home
  2. JYNT vs CMPX Comparison

JYNT vs CMPX Comparison

Compare JYNT & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYNT
  • CMPX
  • Stock Information
  • Founded
  • JYNT 2010
  • CMPX 2014
  • Country
  • JYNT United States
  • CMPX United States
  • Employees
  • JYNT N/A
  • CMPX N/A
  • Industry
  • JYNT Multi-Sector Companies
  • CMPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • JYNT Miscellaneous
  • CMPX Health Care
  • Exchange
  • JYNT Nasdaq
  • CMPX Nasdaq
  • Market Cap
  • JYNT 163.0M
  • CMPX 217.4M
  • IPO Year
  • JYNT 2014
  • CMPX N/A
  • Fundamental
  • Price
  • JYNT $11.50
  • CMPX $1.65
  • Analyst Decision
  • JYNT Strong Buy
  • CMPX Strong Buy
  • Analyst Count
  • JYNT 2
  • CMPX 3
  • Target Price
  • JYNT $18.00
  • CMPX $7.67
  • AVG Volume (30 Days)
  • JYNT 57.5K
  • CMPX 401.9K
  • Earning Date
  • JYNT 11-07-2024
  • CMPX 11-07-2024
  • Dividend Yield
  • JYNT N/A
  • CMPX N/A
  • EPS Growth
  • JYNT N/A
  • CMPX N/A
  • EPS
  • JYNT N/A
  • CMPX N/A
  • Revenue
  • JYNT $120,071,078.00
  • CMPX $850,000.00
  • Revenue This Year
  • JYNT $0.70
  • CMPX N/A
  • Revenue Next Year
  • JYNT N/A
  • CMPX $950.68
  • P/E Ratio
  • JYNT N/A
  • CMPX N/A
  • Revenue Growth
  • JYNT 7.46
  • CMPX N/A
  • 52 Week Low
  • JYNT $7.31
  • CMPX $0.77
  • 52 Week High
  • JYNT $17.82
  • CMPX $2.34
  • Technical
  • Relative Strength Index (RSI)
  • JYNT 48.85
  • CMPX 66.30
  • Support Level
  • JYNT $10.80
  • CMPX $1.42
  • Resistance Level
  • JYNT $12.04
  • CMPX $1.86
  • Average True Range (ATR)
  • JYNT 0.43
  • CMPX 0.14
  • MACD
  • JYNT 0.14
  • CMPX 0.01
  • Stochastic Oscillator
  • JYNT 63.57
  • CMPX 73.53

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.

Share on Social Networks: